Harish C. Pal

2.4k total citations
41 papers, 1.9k citations indexed

About

Harish C. Pal is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Harish C. Pal has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Harish C. Pal's work include Bioactive Compounds and Antitumor Agents (6 papers), Flavonoids in Medical Research (6 papers) and Natural product bioactivities and synthesis (5 papers). Harish C. Pal is often cited by papers focused on Bioactive Compounds and Antitumor Agents (6 papers), Flavonoids in Medical Research (6 papers) and Natural product bioactivities and synthesis (5 papers). Harish C. Pal collaborates with scholars based in United States and India. Harish C. Pal's co-authors include Farrukh Afaq, Craig A. Elmets, Mohammad Athar, Ross Pearlman, Ajit Kumar Saxena, Santosh K. Katiyar, Samriti Sharma, Irum Sehar, Mary Katherine Montes de and Shashi Bhushan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Harish C. Pal

40 papers receiving 1.9k citations

Peers

Harish C. Pal
Won‐Kyung Cho South Korea
Jeongmin Lee South Korea
Ji‐Sun Shin South Korea
Sanguine Byun South Korea
Hyun Lim South Korea
Min‐Kyung Choo United States
Hee‐Sung Chae South Korea
Sungyoul Hong South Korea
Won‐Kyung Cho South Korea
Harish C. Pal
Citations per year, relative to Harish C. Pal Harish C. Pal (= 1×) peers Won‐Kyung Cho

Countries citing papers authored by Harish C. Pal

Since Specialization
Citations

This map shows the geographic impact of Harish C. Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harish C. Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harish C. Pal more than expected).

Fields of papers citing papers by Harish C. Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harish C. Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harish C. Pal. The network helps show where Harish C. Pal may publish in the future.

Co-authorship network of co-authors of Harish C. Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Harish C. Pal. A scholar is included among the top collaborators of Harish C. Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harish C. Pal. Harish C. Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ranjan, Prabhat, Sumanta Goswami, Harish C. Pal, et al.. (2025). Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 328(3). H447–H459. 3 indexed citations
3.
Huijbregts, Richard P. H., et al.. (2022). Optimization of methods for the accurate characterization of whole blood neutrophils. Scientific Reports. 12(1). 3667–3667. 26 indexed citations
4.
Ranjan, Prabhat, et al.. (2022). ALKBH5 Regulates SPHK1-Dependent Endothelial Cell Angiogenesis Following Ischemic Stress. Frontiers in Cardiovascular Medicine. 8. 817304–817304. 37 indexed citations
5.
Ranjan, Prabhat, Sumanta Goswami, Jing Li, et al.. (2021). Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction. Frontiers in Cardiovascular Medicine. 8. 676267–676267. 39 indexed citations
6.
Afaq, Farrukh, Pooja Sharma, Sarah F. McClees, Ross Pearlman, & Harish C. Pal. (2017). 817 Plumbagin inhibits melanoma cell growth and tumorigenicity by inducing ER Stress and DDR signaling. Journal of Investigative Dermatology. 137(5). S140–S140. 2 indexed citations
7.
Pal, Harish C., Ram Prasad, & Santosh K. Katiyar. (2017). Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1. Scientific Reports. 7(1). 1498–1498. 24 indexed citations
8.
Katiyar, Santosh K., Harish C. Pal, & Ram Prasad. (2017). Dietary proanthocyanidins prevent ultraviolet radiation-induced non-melanoma skin cancer through enhanced repair of damaged DNA-dependent activation of immune sensitivity. Seminars in Cancer Biology. 46. 138–145. 35 indexed citations
9.
Pearlman, Ross, Harish C. Pal, Craig A. Elmets, & Farrukh Afaq. (2016). 653 Plumbagin induces apoptosis in melanoma cells by ROS-mediated disruption of mitochondrial membrane potential and inhibition of PI3K/AKT/mTOR signaling. Journal of Investigative Dermatology. 136(5). S115–S115. 4 indexed citations
10.
Pal, Harish C., et al.. (2016). Phytochemicals for the Management of Melanoma. Mini-Reviews in Medicinal Chemistry. 16(12). 953–979. 66 indexed citations
11.
Pal, Harish C., Ross Pearlman, & Farrukh Afaq. (2016). Fisetin and Its Role in Chronic Diseases. Advances in experimental medicine and biology. 928. 213–244. 97 indexed citations
12.
Chamcheu, Jean Christopher, Harish C. Pal, Imtiaz A. Siddiqui, et al.. (2015). Prodifferentiation, Anti-Inflammatory and Antiproliferative Effects of Delphinidin, a Dietary Anthocyanidin, in a Full-Thickness Three-Dimensional Reconstituted Human Skin Model of Psoriasis. Skin Pharmacology and Physiology. 28(4). 177–188. 55 indexed citations
13.
Pal, Harish C., Samriti Sharma, Santosh K. Katiyar, et al.. (2014). Fisetin Inhibits Human Melanoma Cell Invasion through Promotion of Mesenchymal to Epithelial Transition and by Targeting MAPK and NFκB Signaling Pathways. PLoS ONE. 9(1). e86338–e86338. 85 indexed citations
14.
Joshi, Robin, Swati Sood, Dharmesh Kumar, et al.. (2012). In vitro cytotoxicity, antimicrobial, and metal-chelating activity of triterpene saponins from tea seed grown in Kangra valley, India. Medicinal Chemistry Research. 22(8). 4030–4038. 38 indexed citations
15.
Kumar, Ajay, Fayaz Malik, Shashi Bhushan, et al.. (2011). A novel parthenin analog exhibits anti-cancer activity: Activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells. Chemico-Biological Interactions. 193(3). 204–215. 15 indexed citations
16.
Khan, Naghma, Deeba N. Syed, Harish C. Pal, Hasan Mukhtar, & Farrukh Afaq. (2011). Pomegranate Fruit Extract Inhibits UVB‐induced Inflammation and Proliferation by Modulating NF‐κB and MAPK Signaling Pathways in Mouse Skin. Photochemistry and Photobiology. 88(5). 1126–1134. 80 indexed citations
17.
Pal, Harish C., Irum Sehar, Shashi Bhushan, B.D. Gupta, & Ajit Kumar Saxena. (2010). Activation of caspases and poly (ADP-ribose) polymerase cleavage to induce apoptosis in leukemia HL-60 cells by Inula racemosa. Toxicology in Vitro. 24(6). 1599–1609. 64 indexed citations
18.
Verma, Monika, et al.. (2008). Induction of Mitochondrial-Dependent Apoptosis by an Essential Oil from Tanacetum gracile. Planta Medica. 74(5). 515–520. 28 indexed citations
19.
Sharma, Parduman Raj, Dilip M. Mondhe, M. Shanmugavel, et al.. (2008). Anticancer activity of an essential oil from Cymbopogon flexuosus. Chemico-Biological Interactions. 179(2-3). 160–168. 116 indexed citations
20.
Sehar, Irum, Anpurna Kaul, Sarang Bani, Harish C. Pal, & Ajit Kumar Saxena. (2008). Immune up regulatory response of a non-caloric natural sweetener, stevioside. Chemico-Biological Interactions. 173(2). 115–121. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026